ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,732,075 | +34.4% | 100,666 | +52.3% | 0.05% | +63.3% |
| Q2 2023 | $2,032,129 | +76295.8% | 66,107 | -10.5% | 0.03% | -34.8% |
| Q1 2023 | $2,660 | -13.3% | 73,832 | -4.9% | 0.05% | -24.6% |
| Q4 2022 | $3,068 | -99.9% | 77,642 | -6.6% | 0.06% | -20.8% |
| Q3 2022 | $3,341,000 | -11.3% | 83,163 | -7.2% | 0.08% | -7.2% |
| Q2 2022 | $3,767,000 | -19.0% | 89,598 | -24.9% | 0.08% | -6.7% |
| Q1 2022 | $4,648,000 | +59.3% | 119,299 | +104.6% | 0.09% | +29.0% |
| Q4 2021 | $2,918,000 | -37.9% | 58,305 | -55.1% | 0.07% | -25.8% |
| Q3 2021 | $4,698,000 | +18.3% | 129,997 | +34.2% | 0.09% | +19.2% |
| Q2 2021 | $3,970,000 | +55.6% | 96,857 | +65.6% | 0.08% | +30.0% |
| Q1 2021 | $2,551,000 | -12.4% | 58,493 | +0.5% | 0.06% | -15.5% |
| Q4 2020 | $2,912,000 | +187.5% | 58,180 | +141.6% | 0.07% | +153.6% |
| Q3 2020 | $1,013,000 | – | 24,085 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |